Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.16
-0.19 (-2.22%)
May 7, 2026, 3:45 PM EDT - Market open
Cartesian Therapeutics Employees
Cartesian Therapeutics had 75 employees as of December 31, 2025. The number of employees increased by 9 or 13.64% compared to the previous year.
Employees
75
Change (1Y)
9
Growth (1Y)
13.64%
Revenue / Employee
$23,667
Profits / Employee
-$2,023,653
Market Cap
239.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 9 | 13.64% | 75 | 0 |
| Dec 31, 2024 | 66 | 28 | 73.68% | 66 | 0 |
| Dec 31, 2023 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Heron Therapeutics | 128 |
| Adagene | 128 |
| Nkarta | 108 |
| Orchestra BioMed Holdings | 86 |
| Keros Therapeutics | 78 |
| Milestone Pharmaceuticals | 38 |
RNAC News
- 3 days ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 7 days ago - Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 9 days ago - Cartesian Therapeutics management to meet with BTIG - TheFly
- 2 months ago - Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald - TheFly
- 2 months ago - Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald - TheFly
- 2 months ago - Cartesian Therapeutics reports FY25 EPS ($5.02), consensus ($2.35) - TheFly
- 3 months ago - Cartesian Therapeutics announces employment inducement grants - TheFly
- 4 months ago - Cartesian Therapeutics highlights recent progress, outlines 2026 - TheFly